| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ORIC Pharmaceuticals Inc (NASDAQ: ORIC)
ORIC Technical Analysis
5
| As on 9th Jun 2023 ORIC STOCK Price closed @ 5.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.72 & Strong Sell for SHORT-TERM with Stoploss of 11.28 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ORICSTOCK Price
| Open | 5.25 | Change | Price | % |
| High | 5.26 | 1 Day | -0.10 | -1.90 |
| Low | 5.07 | 1 Week | 0.12 | 2.39 |
| Close | 5.15 | 1 Month | 0.14 | 2.79 |
| Volume | 225100 | 1 Year | -9.83 | -65.62 |
| 52 Week High 16.84 | 52 Week Low 2.44 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ORIC Daily Charts |
ORIC Intraday Charts |
Whats New @ Bazaartrend |
ORIC Free Analysis |
|
|
ORIC Important Levels Intraday
| RESISTANCE | 5.52 |
| RESISTANCE | 5.40 |
| RESISTANCE | 5.33 |
| RESISTANCE | 5.25 |
| SUPPORT | 5.05 |
| SUPPORT | 4.97 |
| SUPPORT | 4.90 |
| SUPPORT | 4.78 |
ORIC Forecast April 2024
| 4th UP Forecast | 19.97 |
| 3rd UP Forecast | 15.22 |
| 2nd UP Forecast | 12.28 |
| 1st UP Forecast | 9.34 |
| 1st DOWN Forecast | 0.96 |
| 2nd DOWN Forecast | -1.98 |
| 3rd DOWN Forecast | -4.92 |
| 4th DOWN Forecast | -9.67 |
ORIC Weekly Forecast
| 4th UP Forecast | 10.24 |
| 3rd UP Forecast | 8.61 |
| 2nd UP Forecast | 7.60 |
| 1st UP Forecast | 6.59 |
| 1st DOWN Forecast | 3.71 |
| 2nd DOWN Forecast | 2.70 |
| 3rd DOWN Forecast | 1.69 |
| 4th DOWN Forecast | 0.06 |
ORIC Forecast2024
| 4th UP Forecast | 33.86 |
| 3rd UP Forecast | 24.65 |
| 2nd UP Forecast | 18.96 |
| 1st UP Forecast | 13.27 |
| 1st DOWN Forecast | -2.97 |
| 2nd DOWN Forecast | -8.66 |
| 3rd DOWN Forecast | -14.35 |
| 4th DOWN Forecast | -23.56 |
ORIC Pharmaceuticals Inc ( NASDAQ USA Symbol : ORIC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ORIC Business Profile
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. The company's lead product candidate is ORIC-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. Its other product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple precision medicines targeting other cancer resistance mechanisms. It has collaboration and license agreement with Astellas Pharma, Inc.; Voronoi, Inc.; and Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California. Address: 240 East Grand Avenue, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service